Daniel Grölz
Scientific Associate Director R&D, Sample Technologies Department at QIAGEN
Dr. Daniel Grölz is a Scientific Associate Director of Research and Development at QIAGEN in Hilden, Germany. Dr. Groelz is the R&D project manager who led an international team within PreAnalytiX GmbH to develop the PAXgene Tissue and the PAXgene Blood ccfDNA Systems. He was the leader for the evaluation of the PAXgene Tissue System within the European collaborative grant project, SPIDIA, and manages work packages in two other grant projects to evaluate the PAXgene Tissue and PAXgene Blood ccfDNA Systems for use in routine pathology workflows. He is the main inventor of the PAXgene Tissue System and inventor/co-inventor of the PAXgene Blood ccfDNA stabilization chemistry.
Prior to joining QIAGEN, Dr. Groelz worked for Autoimmun Diagnostika GmbH in Albstadt, Germany. Dr. Groelz received a Ph.D. in Biology from the University of Mainz with a concentration in Physiological Chemistry.
Title: Circulating tumor DNA- preanalytical considerations, international specimen improvement requirements, standards, legislation, technologies
- Need of specimen quality improvement to reduce diagnostic errors
- Pre-analytical factors that influence the outcome of ccfDNA analysis
- International initiatives and requirements to standardize pre-analytical workflows
- Liquid biopsy preservation and workflow solutions